Targeting DLL3 with AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC

被引：27
作者：
Giffin, M. [1 ]
Cooke, K. [1 ]
Lobenhofer, E. [1 ]
Friedrich, M. [1 ]
Raum, T. [1 ]
Coxon, A. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2018.08.1826
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12-03
引用
收藏
页码：S971 / S971
页数：1
相关论文
共 50 条
  • [31] Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110
    Deisting, Wibke
    Raum, Tobias
    Kufer, Peter
    Baeuerle, Patrick A.
    Muenz, Markus
    PLOS ONE, 2015, 10 (10):
  • [32] Rovalpituzumab tesirine Antibody-drug conjugate targeting delta-like protein 3 (DLL3) Treatment of small cell lung cancer
    Gras, J.
    DRUGS OF THE FUTURE, 2018, 43 (04) : 261 - 265
  • [33] TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer
    Nie, Fengqi
    Chen, Yuli
    Hu, Yanming
    Huang, Peng
    Shi, Xuefei
    Cai, Jingsheng
    Qiu, Mantang
    Wang, Enxiu
    Lu, Kaihua
    Sun, Ming
    IMMUNOLOGY, 2024, 172 (03) : 362 - 374
  • [34] AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
    Giffin, Michael J.
    Cooke, Keegan
    Lobenhofer, Edward K.
    Estrada, Juan
    Zhan, Jinghui
    Deegen, Petra
    Thomas, Melissa
    Murawsky, Christopher M.
    Werner, Jonathan
    Liu, Siyuan
    Lee, Fei
    Homann, Oliver
    Friedrich, Matthias
    Pearson, Joshua T.
    Raum, Tobias
    Yang, Yajing
    Caenepeel, Sean
    Stevens, Jennitte
    Beltran, Pedro J.
    Canon, Jude
    Coxon, Angela
    Bailis, Julie M.
    Hughes, Paul E.
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1526 - 1537
  • [35] GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma
    Charan, Manish
    Dravid, Piyush
    Cam, Maren
    Audino, Anthony
    Gross, Amy C.
    Arnold, Michael A.
    Roberts, Ryan D.
    Cripe, Timothy P.
    Pertsemlidis, Alexander
    Houghton, Peter J.
    Cam, Hakan
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (11) : 3184 - 3195
  • [36] Impact of various immune escape mechanisms on redirected lysis by T cells engaged via EpCAM/CD3 bispecific BiTE® antibody AMG 110.
    Deisting, Wibke
    Raum, Tobias
    Kufer, Peter
    Baeuerle, Patrick A.
    Muenz, Markus
    CANCER RESEARCH, 2013, 73 (08)
  • [37] Phase II study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTE®) immuno-oncology therapy targeting DLL3, in third-line or later small cell lung cancer (SCLC)
    Ramalingam, S. S.
    Ahn, M-J.
    Akamatsu, H.
    Blackhall, F.
    Borghaei, H.
    Hummel, H-D.
    Johnson, M.
    Reck, M.
    Zhang, Y.
    Jandial, D.
    Cheng, S.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S103 - S104
  • [38] PD-1/PD-L1 Blocking Enhances CD33/CD3-Bispecific BiTE® Antibody Construct (AMG 330) Mediated Lysis of Primary AML Cells
    Krupka, C.
    Kufer, P.
    Kischel, R.
    Zugmaier, G.
    Lichtenegger, F. S.
    Schnorfeil, F.
    Newhall, K.
    Baeuerle, P. A.
    Hiddemann, W.
    Subklewe, M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S97 - S98
  • [39] Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML
    Laszlo, George S.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Dell'Aringa, Justine
    Newhall, Kathryn J.
    Means, Gary D.
    Sinclair, Angus M.
    Kischel, Roman
    Frankel, Stanley R.
    Walter, Roland B.
    BLOOD, 2014, 123 (04) : 554 - 561
  • [40] PD-1/PD-L1 Blocking Enhances CD33/CD3-Bispecific BiTE® Antibody Construct (AMG 330) Mediated Lysis of Primary AML Cells
    Krupka, C.
    Kufer, P.
    Kischel, R.
    Zugmaier, G.
    Lichtenegger, F. S.
    Schnorfeil, F.
    Newhall, K.
    Baeuerle, P. A.
    Hiddemann, W.
    Subklewe, M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 97 - 98
12345